SCHEMBL31297464

SCHEMBL31297464

CN(CC(=O)O)C(=O)[C@H](N)CCCCN

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.53
DPP9 Q86TI2 3/20 0.45
DPP4 P27487 2/20 0.45
GNAI3 P08754 1/20 0.40
GNAO1 P09471 1/20 0.40
GNAI1 P63096 1/20 0.40
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
NOS2 P35228 1/20 0.39
RNPEP Q9H4A4 1/20 0.39
DPP7 Q9UHL4 5/20 0.37
DPP8 Q6V1X1 2/20 0.37
BHMT Q93088 1/20 0.36
CYP2D6 P10635 1/20 0.36
NFKB1 P19838 1/20 0.36
CPB2 Q96IY4 1/20 0.36
F2 P00734 1/20 0.36
BLM P54132 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6130457 1.00 GSR (0.53) GSRDPP9DPP4GNAI3GNAO1
SCHEMBL6130458 1.00 GSR (0.53) GSRDPP9DPP4GNAI3GNAO1
SCHEMBL29245609 0.82 GSR (0.52) GSRDPP9DPP4GNAI3GNAO1
SCHEMBL11313518 0.81 GSR (0.39) GSRRNPEPCYP2D6NFKB1CPB2
SCHEMBL29750499 0.80 DPP4 (0.67) GSRDPP9DPP4DPP8BHMT
SCHEMBL2280440 0.80 GSR (0.57) GSRDPP9DPP4GNAI3GNAO1
SCHEMBL29615246 0.79 DPP4 (0.47) DPP9DPP4NOS3NOS1NOS2
Hydrochloric Acid SCHEMBL8078485 0.78 GSR (0.55) GSRDPP9DPP4GNAI3GNAO1
Hydrochloric Acid SCHEMBL21931161 0.78 GSR (0.55) GSRDPP9DPP4GNAI3GNAO1
Hydrochloric Acid SCHEMBL14311789 0.78 GSR (0.55) GSRDPP9DPP4GNAI3GNAO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12616739-B2 GLP-1 prodrugs and uses thereof NOVO NORDISK A/S (DK) 2026-05-05 US disclosed
US-20250268986-A1 GLP-1 PRODRUGS AND USES THEREOF NOVO NORDISK A/S (DK) 2025-08-28 US disclosed
CN-119236123-A HSP 90-targeting conjugates and formulations thereof 融合制药公司 2025-01-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250268986-A1 GLP-1 PRODRUGS AND USES THEREOF GLP1R, IAPP, GCG GSR 3142/4885DPP9 17/4885DPP4 6/4885
US-12616739-B2 GLP-1 prodrugs and uses thereof GLP1R, SLC5A1, IAPP GSR 4728/4885DPP9 32/4885DPP4 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.